Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

Lifting the mood on treating fragile X.

Osterweil EK, Kind PC, Bear MF.

Biol Psychiatry. 2012 Dec 1;72(11):895-7. doi: 10.1016/j.biopsych.2012.09.017. No abstract available.

PMID:
23121869
2.

Activation of 5-HT7 serotonin receptors reverses metabotropic glutamate receptor-mediated synaptic plasticity in wild-type and Fmr1 knockout mice, a model of Fragile X syndrome.

Costa L, Spatuzza M, D'Antoni S, Bonaccorso CM, Trovato C, Musumeci SA, Leopoldo M, Lacivita E, Catania MV, Ciranna L.

Biol Psychiatry. 2012 Dec 1;72(11):924-33. doi: 10.1016/j.biopsych.2012.06.008. Epub 2012 Jul 18.

PMID:
22817866
3.

Clarifications on the effects of 5-HT1A agonists and selective 5-HT reuptake inhibitors on the 5-HT system.

Blier P, de Montigny C.

Neuropsychopharmacology. 1996 Aug;15(2):213-6. No abstract available.

4.

Biomedical research. A fix for fragile X syndrome?

Miller G.

Science. 2006 Apr 28;312(5773):521. No abstract available.

PMID:
16645065
5.

Serotonin₆ receptors in the dorsal hippocampus regulate depressive-like behaviors in unilateral 6-hydroxydopamine-lesioned Parkinson's rats.

Liu KC, Li JY, Tan HH, Du CX, Xie W, Zhang YM, Ma WL, Zhang L.

Neuropharmacology. 2015 Aug;95:290-8. doi: 10.1016/j.neuropharm.2015.03.031. Epub 2015 Apr 9.

PMID:
25863121
7.

Reversal of disease-related pathologies in the fragile X mouse model by selective activation of GABAB receptors with arbaclofen.

Henderson C, Wijetunge L, Kinoshita MN, Shumway M, Hammond RS, Postma FR, Brynczka C, Rush R, Thomas A, Paylor R, Warren ST, Vanderklish PW, Kind PC, Carpenter RL, Bear MF, Healy AM.

Sci Transl Med. 2012 Sep 19;4(152):152ra128.

8.

[Effect of antagonists of 5-HT receptors on modulation with serotonin of synaptical activity of projectional neurons of dorsolateral nucleus of rat amygdala].

Masalov IS, Tsvetkov EA, Lokshina EI, Veselkin NP.

Zh Evol Biokhim Fiziol. 2012 Sep-Oct;48(5):455-60. Russian.

PMID:
23136753
9.

Latest advances towards the discovery of 5-HT(7) receptor ligands.

Pittala V, Pittala D.

Mini Rev Med Chem. 2011 Nov;11(13):1108-21. Review.

PMID:
22353220
10.

A single in vivo cocaine administration impairs 5-HT(1B) receptor-induced long-term depression in the nucleus accumbens.

Huang CC, Yeh CM, Wu MY, Hsu KS.

J Neurochem. 2013 Jun;125(6):809-21. doi: 10.1111/jnc.12227. Epub 2013 Mar 19.

11.
12.

The mGluR theory of fragile X mental retardation.

Bear MF, Huber KM, Warren ST.

Trends Neurosci. 2004 Jul;27(7):370-7. Review.

PMID:
15219735
13.

Serotonin receptors of type 6 (5-HT6): from neuroscience to clinical pharmacology.

Marazziti D, Baroni S, Borsini F, Picchetti M, Vatteroni E, Falaschi V, Catena-Dell'Osso M.

Curr Med Chem. 2013;20(3):371-7. Review.

PMID:
23157629
14.

Activation of the 5-HT(6) receptor attenuates long-term potentiation and facilitates GABAergic neurotransmission in rat hippocampus.

West PJ, Marcy VR, Marino MJ, Schaffhauser H.

Neuroscience. 2009 Dec 1;164(2):692-701. doi: 10.1016/j.neuroscience.2009.07.061. Epub 2009 Aug 4.

PMID:
19660530
15.

The 5-HT6 receptor agonist EMD 386088 produces antidepressant and anxiolytic effects in rats after intrahippocampal administration.

Nikiforuk A, Kos T, Wesołowska A.

Psychopharmacology (Berl). 2011 Oct;217(3):411-8. doi: 10.1007/s00213-011-2297-1. Epub 2011 Apr 16.

PMID:
21499701
16.

Targeting 5-HT receptors for the treatment of obesity.

Sargent BJ, Henderson AJ.

Curr Opin Pharmacol. 2011 Feb;11(1):52-8. doi: 10.1016/j.coph.2011.01.005. Epub 2011 Feb 15. Review.

PMID:
21330209
17.

Comparison of 5-hydroxytryptamine1A-mediated hyperpolarization in CA1 and CA3 hippocampal pyramidal cells.

Beck SG, Choi KC, List TJ.

J Pharmacol Exp Ther. 1992 Oct;263(1):350-9.

PMID:
1403796
18.

A brain microdialysis study on 5-HT release in freely moving rat lines selectively bred for differential 5-HT1A receptor function.

Gonzalez LE, Parada MA, Tucci S, Teneud L, Overstreet DH, Hernandez L.

Braz J Med Biol Res. 2003 Feb;36(2):263-7. Epub 2003 Jan 29.

19.

The structure and signalling properties of 5-HT receptors: an endless diversity?

Martin GR, Eglen RM, Hamblin MW, Hoyer D, Yocca F.

Trends Pharmacol Sci. 1998 Jan;19(1):2-4. No abstract available.

PMID:
9509891
20.

Toward selective drug development for the human 5-hydroxytryptamine 1E receptor: a comparison of 5-hydroxytryptamine 1E and 1F receptor structure-affinity relationships.

Klein MT, Dukat M, Glennon RA, Teitler M.

J Pharmacol Exp Ther. 2011 Jun;337(3):860-7. doi: 10.1124/jpet.111.179606. Epub 2011 Mar 21.

Supplemental Content

Support Center